Allworth Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$84.7K Buy
448
+425
+1,848% +$74.3K ﹤0.01% 1944
2025
Q4
$3.96K Buy
23
+5
+28% +$767 ﹤0.01% 3847
2025
Q3
$2.31K Buy
18
+7
+64% +$840 ﹤0.01% 3933
2025
Q2
$1.17K Sell
11
-23
-68% -$2.5K ﹤0.01% 3913
2025
Q1
$3.71K Sell
34
-34
-50% -$4.43K ﹤0.01% 2924
2024
Q4
$8.22K Sell
68
-22
-24% -$2.59K ﹤0.01% 2528
2024
Q3
$10K Sell
90
-9
-9% -$986 ﹤0.01% 2256
2024
Q2
$10.8K Buy
99
+71
+254% +$7.81K ﹤0.01% 2189
2024
Q1
$3.37K Sell
28
-89
-76% -$10.9K ﹤0.01% 2582
2023
Q4
$14.4K Buy
117
+51
+77% +$6.36K ﹤0.01% 1826
2023
Q3
$8.54K Buy
66
+31
+89% +$4.13K ﹤0.01% 1899
2023
Q2
$4.34K Buy
35
+6
+21% +$807 ﹤0.01% 2173
2023
Q1
$4.24K Buy
29
+15
+107% +$2.22K ﹤0.01% 2100
2022
Q4
$2.23K Sell
14
-19
-58% -$2.79K ﹤0.01% 2203
2022
Q3
$4K Buy
33
+30
+1,000% +$4.56K ﹤0.01% 1944
2022
Q2
$0 Hold
3
﹤0.01% 2588
2022
Q1
$0 Buy
3
+2
+200% +$290 ﹤0.01% 2245
2021
Q4
$0 Hold
1
﹤0.01% 2037
2021
Q3
$0 Hold
1
﹤0.01% 1925
2021
Q2
$0 Buy
+1
New +$173 ﹤0.01% 1614
2020
Q2
Sell
-3
Closed 1281
2020
Q1
$0 Hold
3
﹤0.01% 1284
2019
Q4
$0 Hold
3
﹤0.01% 1078
2019
Q3
$0 Hold
3
﹤0.01% 981
2019
Q2
$0 Hold
3
﹤0.01% 992
2019
Q1
$0 Buy
+3
New +$391 ﹤0.01% 996

Other funds holding JAZZ

Allworth Financial's JAZZ Position: Q1 2026 in Review

Allworth Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 1,848% in Q1 2026, buying an estimated $74.3K and bringing the position to 448 shares worth $84.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1944.

Allworth Financial first reported a position in JAZZ in Q1 2019 and has held it in 25 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Allworth Financial held 448 shares of Jazz Pharmaceuticals worth $84.7K as of Q1 2026.
  • Allworth Financial bought 425 Jazz Pharmaceuticals shares in Q1 2026, an estimated $74.3K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #1944 holding.
  • Allworth Financial first reported a position in Jazz Pharmaceuticals in Q1 2019 and has held it in 25 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.